title: Serotonin syndrome following drug-drug interactions and CYP2D6 and CYP2C19 genetic polymorphisms in an HIV-infected patient.
authors.forename: Kuntheavy
authors.initials: K
authors.lastname: I Lorenzini
authors.forename: Alexandra
authors.initials: A
authors.lastname: Calmy
authors.forename: Juan
authors.initials: J
authors.lastname: Ambrosioni
authors.forename: Benjamin
authors.initials: B
authors.lastname: Assouline
authors.forename: Youssef
authors.initials: Y
authors.lastname: Daali
authors.forename: Marc
authors.initials: M
authors.lastname: Fathi
authors.forename: Michela
authors.initials: M
authors.lastname: Rebsamen
authors.forename: Jules
authors.initials: J
authors.lastname: Desmeules
authors.forename: Caroline F
authors.initials: CF
authors.lastname: Samer
mesh_terms: D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000493:pharmacokinetics; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D015283:Citalopram / Q000009:adverse effects* / Q000493:pharmacokinetics; D060085:Coinfection; D065731:Cytochrome P-450 CYP2C19; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics*; D000069454:Darunavir; D003863:Depression / Q000188:drug therapy*; D004347:Drug Interactions; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide; D019438:Ritonavir / Q000009:adverse effects; D020230:Serotonin Syndrome / Q000139:chemically induced / Q000175:diagnosis* / Q000201:enzymology / Q000209:etiology* / Q000235:genetics; D013449:Sulfonamides / Q000009:adverse effects
chemical_list: D018687:Antidepressive Agents, Second-Generation; D017320:HIV Protease Inhibitors; D013449:Sulfonamides; D015283:Citalopram; D001189:Aryl Hydrocarbon Hydroxylases; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19; D019389:Cytochrome P-450 CYP2D6; D019438:Ritonavir; D000069454:Darunavir